U.S. National Institutes of Health
Cancer Diagnosis Program Cancer Imaging Program Cancer Therapy Evaluation Program Developmental Therapeutics Program Radiation Research Program Translational Research Program Biometric Research Branch Office of Cancer Complementary and Alternative Medicine
Last Updated: 08/25/09

Major Initiatives

DCTD Research Interests
This page delineates areas of research interests currently underinvestigated in the DCTD portfolio. More…

The NCI Experimental Therapeutics Program (NExT)
DCTD and the Center for Cancer Research (CCR) are working in close collaboration to reinvigorate cancer drug development at NCI. Through a joint early therapeutics development program, extramural and intramural teams have prioritized a pipeline of NCI-driven targeted therapeutics for development. More…

NCI Chemical Biology Consortium
This program aims to accelerate the discovery and development of effective first-in-class targeted therapies by providing the proper environment to incubate new discoveries and facilitate their growth into full-scale oncologic drug development projects. More…

Evaluating the Predictive and Prognostic Value of Molecular Markers to the Epidermal Growth Factor Receptor in a Phase III Study of Patients with Advanced Non-Small Cell Lung Cancer

Pediatric Clinical Trials Cooperative Groups and Consortia

Improving the Clinical Trials System

Program for the Assessment of Clinical Cancer Tests

Major Imaging Activities

Cancer Complementary and Alternative Medicine Research